Events

EIT Call Info Session: Nuts and bolts of the EIT granting model
OCT
Wed
02
10:30 - 12:00

This was 5 months ago

Location

online

Programmes
Agro-Food, Environment EIT Missions

Webinar in anticipation of the Call for Proposals for a new KIC in the water, marine and maritime sectors and ecosystems. 

During this third webinar participants will learn about the EIT Funding model and how financial sustainability is at the core of the EIT model.

EIT will then dive deeper into the EIT and KIC (Knowledge & Innovation Community) Governance and the EIT Grant Lifecycle and the contractual relationships between the EIT and the KIC.

Finally, there will be a presentation on the monitoring and evaluation instruments that the EIT uses.

More information - here. 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.